MLB removes one name in Biogenesis suit
Two weeks after Major League Baseball filed a lawsuit against Anthony Bosch and five others connected to the now-defunct South Florida anti-aging clinic that allegedly provided performance-enhancing substances to some of the game's biggest names, there was a development in the case Friday.
The ongoing investigation hasn't implicated anybody new. In fact, just the opposite.
In a statement released by the Commissioner's Office, it was announced that "based on new information, [the complaint against] defendant Paulo da Silveira, represented by attorneys Daniel Zumpano and Emil Infante of Infante Zumpano LLC, was dismissed with prejudice from the complaint, filed on March 22, 2013, in the Circuit Court for the Eleventh Judicial Circuit in and for Miami-Dade County, as he had no connection to Biogenesis or to the alleged distribution of performance-enhancing substances to Major League players."
The suit, filed in the 11th Judicial Circuit Court in Miami-Dade County, still covers Biogenesis, Biokem LLC and Bosch, plus Carlos Acevedo, Ricardo J. Martinez, Marcelo Albir and Juan Carlos Nunez. It charges that the defendants "actively participated in a scheme ... to solicit or induce Major League players to purchase or obtain PEDs for their use in violation of MLB's Joint Drug Prevention and Treatment Program."
The filing continues by saying that the defendants "intentionally and unjustifiably interfered" with MLB's drug program, and as a result, "MLB has suffered damages, including the costs of investigation, loss of goodwill, loss of revenue and profits and injury to its reputation, image, strategic advantage and fan relationships."
The filing asks for "monetary damages and other relief resulting from defendants' tortious interference with MLB's contractual relationships."
Alex Rodriguez, Ryan Braun, Melky Cabrera, Nelson Cruz and Gio Gonzalez are among the All-Stars who have been linked to Biogenesis. They were not named in the complaint.
MLB's investigators do not have subpoena power and can't compel testimony, so the filing was intended in part to help them gather evidence. Apparently, they've now found enough, at least, to drop da Silveira from the complaint.